| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1392275-56-7 | Tenofovir alafenamide fumarate;N-((S)-(((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-L-alanine 1-methylethyl ester (2E)-2-butenedioate (2:1); GS 7340-03 | 2(C21H29N6O5P).C4H4O4 |
| 1392278-76-0 | (6S,9S,15S,18R,23R,26S,29S)-18-amino-6-(4-aminobutyl)-9,26-bis(carboxymethyl)-15-(3-(diaminomethylideneamino)propyl)-2,5,8,11,14,17,25,28-octaoxo-20,21-dithia-1,4,7,10,13,16,24,27-octazabicyclo(27.3.0)dotriacontane-23-carboxylic acid;iRGD peptide | C35H57N13O14S2 |
| 1392307-42-4 | 9-(3,4-Dihydroxyphenyl)-2-methoxy-1H-phenalen-1-one | C20H14O4 |
| 1392399-03-9 | BIX 01294 trihydrochloride;2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-(1-(phenylmethyl)-4-piperidinyl)-4-quinazolinamine hydrochloride (1:3) | C28H38N6O2.3(HCl) |
| 1392429-79-6 | N-(3-(5-((1-Ethyl-4-piperidinyl)methylamino)-3-(5-pyrimidinyl)-1H-pyrrolo(3,2-b)pyridin-1-yl)-2,4-difluorophenyl)-1-propanesulfonamide | C28H33F2N7O2S |
| 1392745-70-8 | (1R,3R,4R)-ethyl 4-(tert-butoxycarbonylamino)-3-hydroxycyclohexanecarboxylate | C14H25NO5 |
| 1392803-15-4 | (1R,3R)-rel-3-Aminocyclopentanecarboxylic acid hydrochloride (1:1) | C6H11NO2.HCl |
| 1393124-08-7 | N-(4-((1S)-1-(3,5-Dimethyl-4-(4-(trifluoromethyl)-1H-pyrazol-1-yl)phenoxy)butyl)benzoyl)-beta-alanine | C26H28F3N3O4 |
| 1393350-29-2 | 4-(1,1'-Biphenyl)-4-yl-6-(3,5-dibromophenyl)-2-phenylpyrimidine | C28H18Br2N2 |
| 1393353-34-8 | 3-Bromo-6-quinolineacetic acid ethyl ester;Ethyl 2-(3-bromoquinolin-6-yl)acetate | C13H12BrNO2 |
| 1393442-46-0 | 5-Bromo-2-fluoro-3-methylaniline | C7H7BrFN |
| 1393465-84-3 | 5-(2-Cyclopropylpyrimidin-5-yl)-3-(3-((ethyl(methyl)sulfamoyl)amino)-2,6-difluorobenzoyl)-1H-pyrrolo(2,3-b)pyridine | C24H22F2N6O3S |
| 1393466-87-9 | (3R)-N-(3-((5-(2-Cyclopropyl-5-pyrimidinyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-3-fluoro-1-pyrrolidinesulfonamide;(3R)-N-(3-((5-(2-Cyclopropylpyrimidin-5-yl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-3-fluoropyrrolidine-1-sulfonamide | C25H21F3N6O3S |
| 1393477-72-9 | KPT 330;(2Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-propenoic acid 2-(2-pyrazinyl)hydrazide | C17H11F6N7O |
| 1393527-23-5 | Phosphoric acid 6,6'-di(9-anthryl)-1,1'-spirobiindan-7,7'-diyl ester | C45H31O4P |
| 1393556-48-3 | Azo-Resveratrol | C12H10N2O3 |
| 1393585-06-2 | Oxetane-3-sulfonyl chloride | C3H5ClO3S |
| 1393667-83-8 / 948552-01-0 | 3-Chloro-1H-pyrazole-4-carboxylic acid ethyl ester;Ethyl 3-chloro-1H-pyrazole-4-carboxylate | C6H7ClN2O2 |
| 1393686-89-9 | 4,5-Thiazoledimethanol | C5H7NO2S |
| 1393813-41-6 | N-Propyl-sulfamide potassium salt | C3H11N2O2S.K |
| 1393813-42-7 | N-(5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl)-N'-propylsulfamide | C13H14BrClN4O2S |
| 1393813-43-8 | N-(5-(4-Bromophenyl)-6-(2-hydroxyethoxy)-4-pyrimidinyl)-N'-propylsulfamide | C15H19BrN4O4S |
| 1393823-02-3 | Lithium (thiazol-2-yl)triisopropoxyborate | C12H23BNO3S.Li |
| 1393835-87-4 | 9-(1,1'-Biphenyl)-4-yl-2-bromo-9H-carbazole | C24H16BrN |
| 1393911-57-3 | D-Valganciclovir Hydrochloride;2-((2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)-3-hydroxypropyl valinate hydrochloride (1:1) | C14H23ClN6O5 |
| 1394076-92-6 | 5-(6-(3-Methoxy-3-oxetanyl)-7-methyl-4-(4-morpholinyl)thieno(3,2-d)pyrimidin-2-yl)-2-pyrimidinamine;GNE 317 | C19H22N6O3S |
| 1394371-71-1 | (3R,3aR,6R,6aR)-6-((6-chloro-5-(4-phenylphenyl)-1H-imidazo(4,5-b)pyridin-2-yl)oxy)-2,3,3a,5,6,6a-hexahydrofuro(3,2-b)furan-3-ol;MK8722 | C24H20ClN3O4 |
| 1394374-23-2 | 1-Methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole | C16H21BN2O2 |
| 1394834-50-4 | 9-(4-(9,9-Dimethyl-9H-fluoren-2-yl)quinazolin-2-yl)-9H-carbazole | C35H25N3 |
| 1394840-20-0 | 2,5-Dioxa-8-azaspiro(3.5)nonane hydrochloride | C6H11NO2.HCl |
| 1394842-91-1 | Paroxetine EP Impurity A;Defluoro Paroxetine Hydrochloride;(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-phenylpiperidine;hydrochloride | C19H22ClNO3 |
| 1394854-52-4 | N-(2-(3-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl)-beta-alanine | C22H23N5O2 |
| 1394977-92-4 | 2-Fluoro-5-hydroxy-3-nitrobenzoic acid methyl ester | C8H6FNO5 |
| 1395056-41-3 | Moxifloxacin Impurity 12;1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-((4aS,7aS)-2-oxooctahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-1,4-dihydro-3-quinolinecarboxylic acid | C21H22FN3O5 |
| 1395084-25-9 | 4-((1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl)-N-2-pyridinylbenzenesulfonamide | C18H17N5O3S |
| 1395493-30-7 | Methyl 2-amino-4-bromo-5-fluorobenzoate | C8H7BrFNO2 |
| 1396174-70-1 | Paroxetine EP Impurity E;cis-(+/-)-Paroxetine;(3S,4S)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine | C19H20FNO3 |
| 1396215-84-1 | 4,4,5,5-Tetramethyl-2-(3-oxetanyl)-1,3,2-dioxaborolane | C9H17BO3 |
| 1396607-49-0 | Clopidogrel impurity 2;methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno(3,2-c)pyridin-5-ium-5-yl)acetate;bromide | C16H15BrClNO2S |
| 1396772-26-1 | EPZ 005687;1-Cyclopentyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-6-(4-(morpholinomethyl)phenyl)-1H-indazole-4-carboxamide | C32H37N5O3 |
| 1396841-05-6 | (alphaS)-alpha-(2-Chlorophenyl)-4,7-dihydro-thieno(2,3-c)pyridine-6(5H)-acetic acid methyl ester | C16H16ClNO2S |
| 1397219-81-6 | BS 181 hydrochloride;N5-(6-aminohexyl)-N7-benzyl-3-isopropylpyrazolo((1,5)-a)pyrimidine-5,7-diamine hydrochloride | C22H32N6.HCl |
| 1397237-98-7 | 5-Bromo-4-fluoro-2-methoxybenzenamine | C7H7BrFNO |
| 1397692-46-4 | (3beta)-26,27-Dinorcholest-5-en-24-yne-3,20-diol | C25H38O2 |
| 1397836-49-5 | 2-Ethoxy-1-((2'-(N'-hydroxycarbamimidoyl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylic acid | C24H22N4O4 |
| 1398065-86-5 | 3-(2-chloro-5,6-dihydrobenzo(b)(1)benzazepin-11-yl)-N-methyl-N-(trideuteriomethyl)propan-1-amine hydrochloride | C19H21D3Cl2N2 |
| 1398504-37-4 | 2,4-Dichloro-6-fluorobenzoic acid methyl ester | C8H5Cl2FO2 |
| 1398609-39-6 | Sarolaner;1-(6-((5S)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl)spiro(1H-2-benzofuran-3,3'-azetidine)-1'-yl)-2-methylsulfonylethanone | C23H18Cl2F4N2O5S |
| 1399049-43-4 | Drahebenine;2-Methoxy-4-(2,2,5-trimethyl-2H-imidazol-4-yl)phenol | C13H16N2O2 |
| 1400742-13-3 | 1-(5-Fluoropentyl)-N-tricyclo(3.3.1.13,7)dec-1-yl-1H-indazole-3-carboxamide | C23H30FN3O |